Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program – Contributions to Firms

7204833 Canada inc.

$100,000.00

Scalability with Nervosa

FY 2018-19 · 2018-10-15

Summary
This project will allow Nervosa to be extended, secured and enabled to scale for production state. Key activities involved will be: 1. Enabling access based security and financial transaction capabilities. 2. Build technical reports around statistical validation of model accuracy. 1. Enable entitlement based access where user can be entitled to one or more features of the platform. 2. Enable commercial transaction execution facility - accept payments, reporting and security of information. 3. Validate and publish statistical analysis reflecting accuracy, relevancy of various insights across all models.
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
839792454
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2019-05-10
Agreement Number
914130
Agreement Start Date
2018-10-15
Agreement Title
Scalability with Nervosa
Agreement Title (French)
Evolutivité avec Nervosa
Agreement Type
Contribution
Agreement Value
$100,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will allow Nervosa to be extended, secured and enabled to scale for production state. Key activities involved will be: 1. Enabling access based security and financial transaction capabilities. 2. Build technical reports around statistical validation of model accuracy. 1. Enable entitlement based access where user can be entitled to one or more features of the platform. 2. Enable commercial transaction execution facility - accept payments, reporting and security of information. 3. Validate and publish statistical analysis reflecting accuracy, relevancy of various insights across all models.
Description (French)
Evolutivité avec Nervosa
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Spadina--Fort York
Federal Riding (French)
Spadina--Fort York
Federal Riding Number
35101
NAICS Code
511211
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
839792454
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
7204833 Canada inc.
Recipient Postal Code
M5V 3T1
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q3-914130